首页 > 最新文献

Applied Clinical Research, Clinical Trials and Regulatory Affairs最新文献

英文 中文
Re-print-Significant Findings in Tooth Roots and Jaw Bones Can Cause Serious Diseases 牙根和颌骨可导致严重疾病的重大发现
Pub Date : 2022-05-31 DOI: 10.31579/2693-4779/100
Doepp Manfred
For about 35 years the author has despaired of most of our dentists. In lectures he has often described the majority of dentists as the gravediggers of the people. This has hardly changed since then. While early dentists used to prefer a revealing therapy (see back to the barbers, followed by the dentists), i.e. pulling out diseased teeth, a covering therapy has developed in the last decades. One tries to preserve diseased teeth, among other things with root canal treatments. The more academic dentistry became, the more the relationship between foreign substances in the mouth and the health of the whole body was ignored.
在大约35年的时间里,作者对我们的大多数牙医感到失望。在演讲中,他经常把大多数牙医描述为人民的掘墓人。从那时起,这一点几乎没有改变。虽然早期的牙医倾向于采用暴露疗法(参见理发师,然后是牙医),即拔掉患病的牙齿,但在过去的几十年里,一种覆盖疗法已经发展起来。一种方法是通过根管治疗来保护患病的牙齿。牙科学越学术化,口腔异物与全身健康之间的关系就越被忽视。
{"title":"Re-print-Significant Findings in Tooth Roots and Jaw Bones Can Cause Serious Diseases","authors":"Doepp Manfred","doi":"10.31579/2693-4779/100","DOIUrl":"https://doi.org/10.31579/2693-4779/100","url":null,"abstract":"For about 35 years the author has despaired of most of our dentists. In lectures he has often described the majority of dentists as the gravediggers of the people. This has hardly changed since then. While early dentists used to prefer a revealing therapy (see back to the barbers, followed by the dentists), i.e. pulling out diseased teeth, a covering therapy has developed in the last decades. One tries to preserve diseased teeth, among other things with root canal treatments. The more academic dentistry became, the more the relationship between foreign substances in the mouth and the health of the whole body was ignored.","PeriodicalId":8525,"journal":{"name":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78573434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Research Progress of Foreign Bodies in Digestive Tract 消化道异物的临床研究进展
Pub Date : 2022-05-31 DOI: 10.31579/2693-4779/093
Dao-Hui Wei, Wei Liu
Foreign body of digestive tract refers to the noninherent substances retained in the digestive tract caused by various reasons. Foreign body incarceration is one of the clinical emergencies, occurs at all ages, whose incidence is second only to gastrointestinal bleeding, accounting for about 4% of emergency endoscopic diagnosis and treatment. If not treated timely, foreign body incarceration may cause gastrointestinal erosion, ulcer, bleeding, perforation, obstruction and aortic rupture which is life-threatening. According to the characteristics of patients, dietetical characteristic, types of gastrointestinal foreign bodies, retention time of foreign bodies, incarcerated sites, clinical manifestations, complications, treatment methods, average length of stay and expenses, we explore the research progress of gastrointestinal foreign bodies to improve the level of diagnosis and treatment, as well as increase the cure rate and reduce complications. This review aims to summarize the clinical diagnosis and treatment methods of gastrointestinal foreign bodies for clinicians and strengthen readers' understanding of gastrointestinal foreign bodies.
消化道异物是指由于各种原因而滞留在消化道内的非固有物质。异物嵌顿是临床急症之一,发生于各个年龄段,其发病率仅次于胃肠道出血,约占急诊内镜诊治的4%。如果不及时治疗,异物嵌顿可能引起胃肠道糜烂、溃疡、出血、穿孔、梗阻和主动脉破裂,危及生命。根据患者的特点、饮食特点、胃肠道异物种类、异物滞留时间、嵌顿部位、临床表现、并发症、治疗方法、平均住院时间及费用等,探讨胃肠道异物的研究进展,以提高诊治水平,提高治愈率,减少并发症。本文旨在为临床医生总结胃肠道异物的临床诊断和治疗方法,加强读者对胃肠道异物的认识。
{"title":"Clinical Research Progress of Foreign Bodies in Digestive Tract","authors":"Dao-Hui Wei, Wei Liu","doi":"10.31579/2693-4779/093","DOIUrl":"https://doi.org/10.31579/2693-4779/093","url":null,"abstract":"Foreign body of digestive tract refers to the noninherent substances retained in the digestive tract caused by various reasons. Foreign body incarceration is one of the clinical emergencies, occurs at all ages, whose incidence is second only to gastrointestinal bleeding, accounting for about 4% of emergency endoscopic diagnosis and treatment. If not treated timely, foreign body incarceration may cause gastrointestinal erosion, ulcer, bleeding, perforation, obstruction and aortic rupture which is life-threatening. According to the characteristics of patients, dietetical characteristic, types of gastrointestinal foreign bodies, retention time of foreign bodies, incarcerated sites, clinical manifestations, complications, treatment methods, average length of stay and expenses, we explore the research progress of gastrointestinal foreign bodies to improve the level of diagnosis and treatment, as well as increase the cure rate and reduce complications. This review aims to summarize the clinical diagnosis and treatment methods of gastrointestinal foreign bodies for clinicians and strengthen readers' understanding of gastrointestinal foreign bodies.","PeriodicalId":8525,"journal":{"name":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90873026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined Extraction (Cystourethroscopy and Suprapubic Cystotomy) of A Selfinserted Hairpin Located In The Posterior Urethra - A 7-Year-Old Boy 膀胱尿道镜联合耻骨上膀胱切开术治疗7岁男童后尿道自置发夹
Pub Date : 2022-05-31 DOI: 10.31579/2693-4779/097
K. Karavdić, A. Firdus, M. A., Đogić H, Altunbabić L, Dewan P.A
Self-inserted urethrovesical foreign bodies are rare in children. A 7-year-old boy inserted a hairpin into the urethra seven days before admission, a diagnosis that was made on the basis of the appearance of blood in the urine, palpation of the base of the penis and two directional X-ray imaging. Cystourethroscopy and suprapubic cystotomy were used to remove the foreign body.The presentation of urethrovesical foreign bodies can vary widely, as can the type of object inserted. Definitive treatment is usually the endoscopic removal, however occasionally surgical intervention may be required. Our novel approach enabled less traumatic removal of the hairpin
自插尿道异物在儿童中很少见。一个7岁的男孩在入院前7天将一个发夹插入尿道,诊断是根据尿中带血的外观,触诊阴茎底部和两个定向x线成像。采用膀胱输尿管镜和耻骨上膀胱切开术切除异物。尿道异物的表现可以有很大的不同,插入物的类型也有很大的不同。最终的治疗通常是内窥镜切除,但偶尔也需要手术干预。我们的新方法使取发夹的创伤性更小
{"title":"Combined Extraction (Cystourethroscopy and Suprapubic Cystotomy) of A Selfinserted Hairpin Located In The Posterior Urethra - A 7-Year-Old Boy","authors":"K. Karavdić, A. Firdus, M. A., Đogić H, Altunbabić L, Dewan P.A","doi":"10.31579/2693-4779/097","DOIUrl":"https://doi.org/10.31579/2693-4779/097","url":null,"abstract":"Self-inserted urethrovesical foreign bodies are rare in children. A 7-year-old boy inserted a hairpin into the urethra seven days before admission, a diagnosis that was made on the basis of the appearance of blood in the urine, palpation of the base of the penis and two directional X-ray imaging. Cystourethroscopy and suprapubic cystotomy were used to remove the foreign body.The presentation of urethrovesical foreign bodies can vary widely, as can the type of object inserted. Definitive treatment is usually the endoscopic removal, however occasionally surgical intervention may be required. Our novel approach enabled less traumatic removal of the hairpin","PeriodicalId":8525,"journal":{"name":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75358176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seminal Vesicle Adenocarcinoma Associated with Zinner Syndrome: Case Report and Literature Review 精囊腺癌伴津纳综合征:病例报告及文献回顾
Pub Date : 2022-05-31 DOI: 10.31579/2693-4779/099
Corina Florica Ioniță, A. Gomotirceanu, Daniela Cojocaru, F. Costea, O. Pop
The Zinner Syndrome is a rare congenital malformation represented by a triad of characteristics: ipsilateral renal agenesis, seminal vesicle cysts and ejaculatory duct obstruction. The aim of this study is to present a 69 year old man case, with seminal vesicle adenocarcinoma developed in association with Zinner Syndrome.First off all, patient presented with severe urinary retention. Had clinical and imaging examinations: ultrasound scan, computed tomography of the chest, abdomen and pelvis, abdominal-pelvic MRI and biochemical evaluation: PSA. As a result, diagnosis of Zinner Syndrome has been established and was suspected a carcinoma of seminal vesicle. The pacient underwent robotic removal of the tumoral cyst. The postoperative evolution of the patient was uneventful. The diagnosis of seminal vesicle adenocarcinoma was confirmed by immunohistochemistry, staining negative for PSA and positive for CK7. Seminal vesicle carcinomas are particularly rare. Their occurrence in patients with Zinner Syndrome is exceptional, but should be considered in differential diagnosis of pelvic tumors.
Zinner综合征是一种罕见的先天性畸形,表现为三种特征:同侧肾发育不全,精囊囊肿和射精管阻塞。本研究的目的是提出一个69岁的男子病例,精囊腺癌发展与津纳综合征相关。首先,病人表现出严重的尿潴留。进行临床及影像学检查:超声扫描、胸腹骨盆计算机断层扫描、腹盆MRI及生化评价:PSA。结果,津纳综合征的诊断已确立,并怀疑为精囊癌。病人接受了机器人切除肿瘤囊肿的手术。患者术后进展顺利。精囊腺癌的诊断经免疫组化证实,PSA染色阴性,CK7染色阳性。精囊癌尤其罕见。它们发生在Zinner综合征患者中是例外,但在盆腔肿瘤的鉴别诊断中应予以考虑。
{"title":"Seminal Vesicle Adenocarcinoma Associated with Zinner Syndrome: Case Report and Literature Review","authors":"Corina Florica Ioniță, A. Gomotirceanu, Daniela Cojocaru, F. Costea, O. Pop","doi":"10.31579/2693-4779/099","DOIUrl":"https://doi.org/10.31579/2693-4779/099","url":null,"abstract":"The Zinner Syndrome is a rare congenital malformation represented by a triad of characteristics: ipsilateral renal agenesis, seminal vesicle cysts and ejaculatory duct obstruction. The aim of this study is to present a 69 year old man case, with seminal vesicle adenocarcinoma developed in association with Zinner Syndrome.First off all, patient presented with severe urinary retention. Had clinical and imaging examinations: ultrasound scan, computed tomography of the chest, abdomen and pelvis, abdominal-pelvic MRI and biochemical evaluation: PSA. As a result, diagnosis of Zinner Syndrome has been established and was suspected a carcinoma of seminal vesicle. The pacient underwent robotic removal of the tumoral cyst. The postoperative evolution of the patient was uneventful. The diagnosis of seminal vesicle adenocarcinoma was confirmed by immunohistochemistry, staining negative for PSA and positive for CK7. Seminal vesicle carcinomas are particularly rare. Their occurrence in patients with Zinner Syndrome is exceptional, but should be considered in differential diagnosis of pelvic tumors.","PeriodicalId":8525,"journal":{"name":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87525168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conservative Blood Management and Parameters That We Should Take into Account to Avoid Transfusions in A Jehovah’s Witness Patient 保守的血液管理和参数,我们应该考虑避免输血给耶和华见证人的病人
Pub Date : 2022-05-31 DOI: 10.31579/2693-4779/098
Marina Ayres Delgado, Luana Assis Ferreira, Lorena Machado Marques Faria, Jadson Lardy Lemes
Jehovah’s witness refusion to blood products is based on the interpretation of the bible as blood transfusion carries itself potential risks and is a special issue in this group of patients this report suggest that blood transfusion should be guided by personal triggers, based on hemodynamic and laboratory indices associated with age and comorbidities.
耶和华见证人拒绝使用血液制品是基于对圣经的解释,因为输血本身有潜在的风险,是这类患者的一个特殊问题。这份报告建议,输血应根据个人触发因素,根据与年龄和合并症相关的血液动力学和实验室指标来指导。
{"title":"Conservative Blood Management and Parameters That We Should Take into Account to Avoid Transfusions in A Jehovah’s Witness Patient","authors":"Marina Ayres Delgado, Luana Assis Ferreira, Lorena Machado Marques Faria, Jadson Lardy Lemes","doi":"10.31579/2693-4779/098","DOIUrl":"https://doi.org/10.31579/2693-4779/098","url":null,"abstract":"Jehovah’s witness refusion to blood products is based on the interpretation of the bible as blood transfusion carries itself potential risks and is a special issue in this group of patients this report suggest that blood transfusion should be guided by personal triggers, based on hemodynamic and laboratory indices associated with age and comorbidities.","PeriodicalId":8525,"journal":{"name":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77288592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cryotherapy As Treatment of Curative Intent for Localized Adenocarcinoma of The Prostate Gland with A Focus on Low-risk and Medium – (Intermediate-) Risk Localized Adenocarcinoma of The Prostate Gland: A Review and Update 冷冻疗法作为局部前列腺腺癌的治疗目的,重点是低风险和中(中)风险的局部前列腺腺癌:综述和最新进展
Pub Date : 2022-04-27 DOI: 10.31579/2693-4779/083
A. Kodzo-Grey Venyo
Cryotherapy which is also referred to as cryosurgery or cryoablation refers to utilization of very cold temperatures to freeze various cells depending upon the pathology. Cryotherapy has tended to be utilized as treatment of curative intent for localized low-risk and intermediate risk carcinomas of the prostate gland. Cryotherapy has also been utilized for the treatment of post-cryotherapy failure prostate cancers with residual tumour or locally recurrent tumour that is confined to the prostate gland. Cryotherapy has also been utilized for the treatment of locally recurrent prostate cancers or localized prostate cancers that have remained following failure of radiotherapy to the prostate cancer of curative intent or radical prostatectomy of prostate for prostate at times. Because cryotherapy of prostate cancer is a minimally invasive treatment procedure, it can be utilized in the treatment of patients who have localized prostate cancer whose tumours could be treated by means of radical prostatectomy or radiotherapy (external beam radiotherapy or brachytherapy) who are considered not to be medically fit to undergo these procedures because of their co-morbidities. The most common treatment options for the management of localized adenocarcinomas of the prostate gland tend to involve radical prostatectomy or radical radiotherapy. Nevertheless, other treatment options for localized prostate cancer that have been undertaken sporadically include: Radiofrequency ablation of the prostate cancer, High intensity focussed ultrasound scan treatment of prostate cancer, irreversible electroporation of prostate cancer. Cryotherapy of prostate cancer as treatment of curative intent has tended to be published sporadically based upon case reports or case series and there has not been reports of an extensive clinical-trials on cryotherapy of localized adenocarcinoma of the prostate. Furthermore, there is no consensus opinion validated definition of biochemical failure pursuant to treatment of localized prostate cancer by cryotherapy. Nevertheless, one article has reported a prospective study with the undertaking of standardized follow-up protocol in which it a series of 108 patients who were diagnosed as having localized adenocarcinoma of prostate that was staged T1c to T2c were treated by primary cryoablation of curative intent and in which the median follow-up was 61 months. With regard to the results of this study, the criteria of biochemical recurrence had been unified based upon the American Society for Therapeutic Radiology and Oncology (ASTRO). The end points of the study included: biochemical progression-free survival (BPFS), cancer-specific survival, as well as overall survival. The complication rates were reported in the study. With regard to the results the biochemical progression-free survival rates were for low-, medium-, and high-risk prostate cancer patients 96.4%, 91.2%, and 62.2%, respectively. The Cancer-specific survival was 98.1%. The overall sur
与根治性前列腺切除术或根治性放疗相比,前列腺癌冷冻治疗后出现的勃起/性功能障碍、尿失禁/排尿功能障碍等并发症更为短暂。对于低风险和中风险的局限性前列腺癌患者,冷冻治疗的长期肿瘤预后可能略低于根治性前列腺切除术、根治性放疗和其他具有治疗目的的微创治疗方案,但这需要通过大规模的全球多中心治疗对比研究和长期随访来进一步研究。然而,前列腺癌冷冻治疗确实是一种微创替代治疗局部前列腺癌作为治疗目的的治疗方法,它也可以用于治疗根治性放疗和根治性前列腺切除术后的持续性/局部复发性前列腺癌。冷冻治疗是局部低危、中危前列腺癌安全有效的治疗方法。
{"title":"Cryotherapy As Treatment of Curative Intent for Localized Adenocarcinoma of The Prostate Gland with A Focus on Low-risk and Medium – (Intermediate-) Risk Localized Adenocarcinoma of The Prostate Gland: A Review and Update","authors":"A. Kodzo-Grey Venyo","doi":"10.31579/2693-4779/083","DOIUrl":"https://doi.org/10.31579/2693-4779/083","url":null,"abstract":"Cryotherapy which is also referred to as cryosurgery or cryoablation refers to utilization of very cold temperatures to freeze various cells depending upon the pathology. Cryotherapy has tended to be utilized as treatment of curative intent for localized low-risk and intermediate risk carcinomas of the prostate gland. Cryotherapy has also been utilized for the treatment of post-cryotherapy failure prostate cancers with residual tumour or locally recurrent tumour that is confined to the prostate gland. Cryotherapy has also been utilized for the treatment of locally recurrent prostate cancers or localized prostate cancers that have remained following failure of radiotherapy to the prostate cancer of curative intent or radical prostatectomy of prostate for prostate at times. Because cryotherapy of prostate cancer is a minimally invasive treatment procedure, it can be utilized in the treatment of patients who have localized prostate cancer whose tumours could be treated by means of radical prostatectomy or radiotherapy (external beam radiotherapy or brachytherapy) who are considered not to be medically fit to undergo these procedures because of their co-morbidities. The most common treatment options for the management of localized adenocarcinomas of the prostate gland tend to involve radical prostatectomy or radical radiotherapy. Nevertheless, other treatment options for localized prostate cancer that have been undertaken sporadically include: Radiofrequency ablation of the prostate cancer, High intensity focussed ultrasound scan treatment of prostate cancer, irreversible electroporation of prostate cancer. Cryotherapy of prostate cancer as treatment of curative intent has tended to be published sporadically based upon case reports or case series and there has not been reports of an extensive clinical-trials on cryotherapy of localized adenocarcinoma of the prostate. Furthermore, there is no consensus opinion validated definition of biochemical failure pursuant to treatment of localized prostate cancer by cryotherapy. Nevertheless, one article has reported a prospective study with the undertaking of standardized follow-up protocol in which it a series of 108 patients who were diagnosed as having localized adenocarcinoma of prostate that was staged T1c to T2c were treated by primary cryoablation of curative intent and in which the median follow-up was 61 months. With regard to the results of this study, the criteria of biochemical recurrence had been unified based upon the American Society for Therapeutic Radiology and Oncology (ASTRO). The end points of the study included: biochemical progression-free survival (BPFS), cancer-specific survival, as well as overall survival. The complication rates were reported in the study. With regard to the results the biochemical progression-free survival rates were for low-, medium-, and high-risk prostate cancer patients 96.4%, 91.2%, and 62.2%, respectively. The Cancer-specific survival was 98.1%. The overall sur","PeriodicalId":8525,"journal":{"name":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87563989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peculiar Therapeutic Property of Camel’s (Camelus dromedarius) Urine Against Multidrug Resistant Bacteria 骆驼(Camelus dromedarius)尿液对多重耐药细菌的特殊治疗特性
Pub Date : 2022-04-27 DOI: 10.31579/2693-4779/089
V. Bhardwaj
The remedial use of camel urine has been known for centuries, with evidence of its use for curative purposes found in early folklore. It has been used to cure different diseases; however, the significant therapeutic benefits of urine have yet to undergo rigorous scientific evaluation. The exploration of the use of camel urine is of great interest to determine their efficacy in pharmaceutical industry. This study investigated the effect of camel’s urine against five human pathogenic bacteria, to determine their efficacy against multidrug resistant microbes. The probe was done by agar well diffusion method. Multidrug resistant (MDR) strains of Bacillus subtilis (ATCC 6633), E. coli (ATCC 8739), Salmonella enterica (ATCC 14028), Staphylococcus aureus (ATCC 6538), Pseudomonas aeruginosa (ATCC 27853) were used in the study. Ciprofloxacin was used as standard. Maximum zone of inhibition was observed with Salmonella enterica which is 33 ± 0.2 mm. Additionally, Multidrug resistant (MDR) strains of E. coli, Pseudomonas aeruginosa and Staphylococcus aureus was strongly inhibited by camel’s urine. Moreover, MDR strains of Bacillus subtilis, also shows inhibition. The potency shown by camel’s urine for therapeutic action, recommends their use against multidrug resistant microorganisms. In this research work, scientific evidence has been presented that supports, therapeutic capabilities of camel’s urine which exhibited a potential antibacterial activity against the tested microorganisms and could be a potential source of new antimicrobial agents.
骆驼尿的治疗用途已经知道了几个世纪,在早期的民间传说中发现了它用于治疗目的的证据。它被用来治疗不同的疾病;然而,尿液的显著治疗效益尚未经过严格的科学评估。探索骆驼尿的利用对确定其在制药工业中的功效具有重要意义。本研究考察了骆驼尿液对5种人类致病菌的作用,以确定其对多重耐药微生物的作用。探针采用琼脂孔扩散法。采用多药耐药菌株枯草芽孢杆菌(ATCC 6633)、大肠杆菌(ATCC 8739)、肠沙门氏菌(ATCC 14028)、金黄色葡萄球菌(ATCC 6538)、铜绿假单胞菌(ATCC 27853)进行研究。以环丙沙星为标准品。对肠沙门氏菌的最大抑制区为33±0.2 mm。此外,多药耐药(MDR)菌株大肠杆菌、铜绿假单胞菌和金黄色葡萄球菌被骆驼尿液强烈抑制。此外,耐多药菌株对枯草芽孢杆菌也有抑制作用。骆驼尿液所显示的治疗作用的效力,建议它们用于对抗多重耐药微生物。在这项研究工作中,已经提出了科学证据,支持骆驼尿液的治疗能力,骆驼尿液对被测微生物显示出潜在的抗菌活性,可能是新的抗菌药物的潜在来源。
{"title":"Peculiar Therapeutic Property of Camel’s (Camelus dromedarius) Urine Against Multidrug Resistant Bacteria","authors":"V. Bhardwaj","doi":"10.31579/2693-4779/089","DOIUrl":"https://doi.org/10.31579/2693-4779/089","url":null,"abstract":"The remedial use of camel urine has been known for centuries, with evidence of its use for curative purposes found in early folklore. It has been used to cure different diseases; however, the significant therapeutic benefits of urine have yet to undergo rigorous scientific evaluation. The exploration of the use of camel urine is of great interest to determine their efficacy in pharmaceutical industry. This study investigated the effect of camel’s urine against five human pathogenic bacteria, to determine their efficacy against multidrug resistant microbes. The probe was done by agar well diffusion method. Multidrug resistant (MDR) strains of Bacillus subtilis (ATCC 6633), E. coli (ATCC 8739), Salmonella enterica (ATCC 14028), Staphylococcus aureus (ATCC 6538), Pseudomonas aeruginosa (ATCC 27853) were used in the study. Ciprofloxacin was used as standard. Maximum zone of inhibition was observed with Salmonella enterica which is 33 ± 0.2 mm. Additionally, Multidrug resistant (MDR) strains of E. coli, Pseudomonas aeruginosa and Staphylococcus aureus was strongly inhibited by camel’s urine. Moreover, MDR strains of Bacillus subtilis, also shows inhibition. The potency shown by camel’s urine for therapeutic action, recommends their use against multidrug resistant microorganisms. In this research work, scientific evidence has been presented that supports, therapeutic capabilities of camel’s urine which exhibited a potential antibacterial activity against the tested microorganisms and could be a potential source of new antimicrobial agents.","PeriodicalId":8525,"journal":{"name":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83349735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Mini-review about Concomitant Burn and COVID-19 关于伴随烧伤与COVID-19的综述
Pub Date : 2022-04-27 DOI: 10.31579/2693-4779/094
M. Hesamirostami, Sanli Hesamirostami, Alireza Sanei Motlagh
COVID-19 can cause different catastrophic events and mortalities. Therefore, burn hospitals strategies changed during regional peak of COVID-19 pandemic in the world. Some outpatient strategies were introduced to minimize the contact with infected patients. However, admission strategies were based on the severity of COVID-19 symptoms and also severity of burn injuries. The policy for admission to give inpatient care relates to history, symptoms and COVID-19 PCR results. If all the mentioned criteria were negative, the burn patient was admitted to GREEN area or ward. If the patient was suspected or positive for COVID-19, then would be admitted to RED area or ward. Given that some patients may be carriers without specific symptoms, considering a YELLOW area or ward seems logical for these groups. In GREEN areas one care giver for each adult and two care givers for each pediatric patient were allowed. For all care givers wearing medical masks were obligatory. All patients, care givers and staffs were under constant surveillance for fever and other symptoms. In RED areas no visitors were allowed and for each patient one nurse was assigned in BICU. All elective surgeries were stopped and other procedures were divided to emergency and semi-emergency. Strategies for facing COVID-19 surges especially new variants need to continuously evolve. Changing of infectivity rate, manifestations, resistance to different vaccine and duration of viral shedding necessitate modification of principles according to data collected from involving countries.
COVID-19可导致不同的灾难性事件和死亡。因此,在全球COVID-19大流行的区域高峰期间,烧伤医院的策略发生了变化。介绍了一些门诊策略,以尽量减少与感染患者的接触。然而,入院策略是基于COVID-19症状的严重程度和烧伤的严重程度。住院治疗政策涉及病史、症状和COVID-19 PCR结果。如上述各项指标均为阴性,则该烧伤患者入住GREEN区或病房。如果患者被怀疑或呈COVID-19阳性,则将被送入RED区或病房。考虑到一些患者可能是没有特定症状的携带者,考虑将这些群体划分为黄色区域或病房似乎是合乎逻辑的。在绿色区域,每名成人允许有一名护理人员,每名儿科患者允许有两名护理人员。所有护理人员都必须佩戴医用口罩。所有患者、护理人员和工作人员都受到持续监测,以防发烧和其他症状。在红色区域不允许访客,每个病人在BICU有一名护士。所有选择性手术均停止,其他手术分为急诊和半急诊。应对COVID-19激增的战略,特别是新变体需要不断发展。感染率、表现、对不同疫苗的耐药性和病毒脱落持续时间的变化需要根据从有关国家收集的数据修改原则。
{"title":"A Mini-review about Concomitant Burn and COVID-19","authors":"M. Hesamirostami, Sanli Hesamirostami, Alireza Sanei Motlagh","doi":"10.31579/2693-4779/094","DOIUrl":"https://doi.org/10.31579/2693-4779/094","url":null,"abstract":"COVID-19 can cause different catastrophic events and mortalities. Therefore, burn hospitals strategies changed during regional peak of COVID-19 pandemic in the world. Some outpatient strategies were introduced to minimize the contact with infected patients. However, admission strategies were based on the severity of COVID-19 symptoms and also severity of burn injuries. The policy for admission to give inpatient care relates to history, symptoms and COVID-19 PCR results. If all the mentioned criteria were negative, the burn patient was admitted to GREEN area or ward. If the patient was suspected or positive for COVID-19, then would be admitted to RED area or ward. Given that some patients may be carriers without specific symptoms, considering a YELLOW area or ward seems logical for these groups. In GREEN areas one care giver for each adult and two care givers for each pediatric patient were allowed. For all care givers wearing medical masks were obligatory. All patients, care givers and staffs were under constant surveillance for fever and other symptoms. In RED areas no visitors were allowed and for each patient one nurse was assigned in BICU. All elective surgeries were stopped and other procedures were divided to emergency and semi-emergency. Strategies for facing COVID-19 surges especially new variants need to continuously evolve. Changing of infectivity rate, manifestations, resistance to different vaccine and duration of viral shedding necessitate modification of principles according to data collected from involving countries.","PeriodicalId":8525,"journal":{"name":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75317263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Study of active medicinal plant (Artemisia Judaica) against Staphylococcus aureus 活性药用植物犹太蒿抗金黄色葡萄球菌的研究
Pub Date : 2022-04-27 DOI: 10.31579/2693-4779/092
Elmanakhly Mohammed Emam, Anna I. Marakhova
Staphylococcus aureus infection is a rather insidious disease. If tests have shown that Staphylococcus aureus is found on the skin, intestines, ears or nasopharynx, Treatment with pharmaceutical drugs extracted from medicinal plants can be a way to get rid of infection. Plants are considered the greatest source to obtain new antimicrobials. The present study aimed at evaluating the in vitro antimicrobial activity of methanolic extracts of Artemisia Judaica plant against Staphylococcus aureus Sp. and others pathogenic bacteria, these bacteria are commonly found in hospital-acquired infections. The methanolic extract of Artemisia Judaica effective against the isolates microorganisms, S. aureus, E. coli, P. aeruginosa, The diameter of zone of inhibition was found to be in the range of 14 – 30 mm against various bacterial strains tested, with maximum diameter against bacteria (S. aureus, 30 mm). The methanolic extract of Artemisia Judaica presented the highest anti-staphylococcus aureus activity and was effective against others bacterial strains tested.
金黄色葡萄球菌感染是一种相当隐蔽的疾病。如果测试表明在皮肤、肠道、耳朵或鼻咽上发现金黄色葡萄球菌,使用从药用植物中提取的药物治疗可能是摆脱感染的一种方法。植物被认为是获得新型抗菌剂的最大来源。本研究旨在评价青蒿植物甲醇提取物对医院获得性感染中常见的金黄色葡萄球菌等病原菌的体外抑菌活性。对金黄色葡萄球菌、大肠杆菌、铜绿假单胞菌的抑菌带直径在14 ~ 30 mm范围内,对金黄色葡萄球菌的抑菌带最大直径为30 mm。其中,青蒿甲醇提取物的抗金黄色葡萄球菌活性最高,对其他菌株也有较好的抑制作用。
{"title":"A Study of active medicinal plant (Artemisia Judaica) against Staphylococcus aureus","authors":"Elmanakhly Mohammed Emam, Anna I. Marakhova","doi":"10.31579/2693-4779/092","DOIUrl":"https://doi.org/10.31579/2693-4779/092","url":null,"abstract":"Staphylococcus aureus infection is a rather insidious disease. If tests have shown that Staphylococcus aureus is found on the skin, intestines, ears or nasopharynx, Treatment with pharmaceutical drugs extracted from medicinal plants can be a way to get rid of infection. Plants are considered the greatest source to obtain new antimicrobials. The present study aimed at evaluating the in vitro antimicrobial activity of methanolic extracts of Artemisia Judaica plant against Staphylococcus aureus Sp. and others pathogenic bacteria, these bacteria are commonly found in hospital-acquired infections. The methanolic extract of Artemisia Judaica effective against the isolates microorganisms, S. aureus, E. coli, P. aeruginosa, The diameter of zone of inhibition was found to be in the range of 14 – 30 mm against various bacterial strains tested, with maximum diameter against bacteria (S. aureus, 30 mm). The methanolic extract of Artemisia Judaica presented the highest anti-staphylococcus aureus activity and was effective against others bacterial strains tested.","PeriodicalId":8525,"journal":{"name":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91024226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Making the best use of CT Quantification Scores in Management of COVID-19 Patients 充分利用CT量化评分在COVID-19患者管理中的作用
Pub Date : 2022-04-27 DOI: 10.31579/2693-4779/091
Alireza Almasi Nokiani
Because of the primary involvement of the respiratory system, chest computed tomography (CT) is strongly recommended in suspected COVID-19 cases, for both initial evaluation and follow-up [1]. At least seven scoring systems using chest CT have been proposed to quantify lung involvement in COVID-19 which are summarized in table 1 [1-10] and we use the term CT severity score (CTSS) to refer to them with numbers 1-7 to refer to a specific scoring system.
由于主要累及呼吸系统,强烈建议在疑似COVID-19病例中进行胸部计算机断层扫描(CT),进行初步评估和随访[1]。目前已经提出了至少七种使用胸部CT的评分系统来量化COVID-19对肺部的损害,如表1所示[1-10],我们使用术语CT严重性评分(CTSS)来指代它们,用数字1-7来指代特定的评分系统。
{"title":"Making the best use of CT Quantification Scores in Management of COVID-19 Patients","authors":"Alireza Almasi Nokiani","doi":"10.31579/2693-4779/091","DOIUrl":"https://doi.org/10.31579/2693-4779/091","url":null,"abstract":"Because of the primary involvement of the respiratory system, chest computed tomography (CT) is strongly recommended in suspected COVID-19 cases, for both initial evaluation and follow-up [1]. At least seven scoring systems using chest CT have been proposed to quantify lung involvement in COVID-19 which are summarized in table 1 [1-10] and we use the term CT severity score (CTSS) to refer to them with numbers 1-7 to refer to a specific scoring system.","PeriodicalId":8525,"journal":{"name":"Applied Clinical Research, Clinical Trials and Regulatory Affairs","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82746030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Applied Clinical Research, Clinical Trials and Regulatory Affairs
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1